HIBISCUS: Hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndrome.

MLA

Belizna, Cristina, et al. “HIBISCUS: Hydroxychloroquine for the Secondary Prevention of Thrombotic and Obstetrical Events in Primary Antiphospholipid Syndrome.” Autoimmunity Reviews, vol. 17, no. 12, Dec. 2018, pp. 1153–68. EBSCOhost, https://doi.org/10.1016/j.autrev.2018.05.012.

APA

Belizna, C., Pregnolato, F., Abad, S., Alijotas-Reig, J., Amital, H., Amoura, Z., Andreoli, L., Andres, E., Aouba, A., Apras Bilgen, S., Arnaud, L., Bienvenu, B., Bitsadze, V., Blanco, P., Blank, M., Borghi, M. O., Caligaro, A., Candrea, E., Canti, V., … Meroni, P. L. (2018). HIBISCUS: Hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndrome. Autoimmunity Reviews, 17(12), 1153–1168. https://doi.org/10.1016/j.autrev.2018.05.012

Chicago

Belizna, Cristina, Francesca Pregnolato, Sebastien Abad, Jaume Alijotas-Reig, Howard Amital, Zahir Amoura, Laura Andreoli, et al. 2018. “HIBISCUS: Hydroxychloroquine for the Secondary Prevention of Thrombotic and Obstetrical Events in Primary Antiphospholipid Syndrome.” Autoimmunity Reviews 17 (12): 1153–68. doi:10.1016/j.autrev.2018.05.012.